A new publication into the benefits of spironolactone (Prilactone - CEVA Animal Health) has supported its use as part of first-line therapy for the treatment of dogs with congestive heart failure caused by mitral heart disease, according to CEVA.

The…

Ceva Animal Health has announced the launch of Cardalis for the treatment of canine heart failure caused by degenerative valvular heart disease.

Cardalis contains what the company says is a unique combination of benazepril and spironolactone in one…

Ceva Animal Health has launched a competition - open to veterinary surgeons and nurses - to support Cardalis (benazepril and spironolactone), its dual-acting treatment for heart failure in dogs.

To enter the competition, which will run till the end…

Ceva Animal Health has launched Libeo, a new four-way break, palatable furosemide for the management of heart failure in dogs.

According to the company, furosemide - a diuretic - is the most frequently used treatment for the management of heart failure…

Ceva Animal Health has launched what it describes as a new and improved spironolactone, Prilactone Next, for the treatment of congestive heart failure caused by degenerative mitral valve disease in dogs.

Prilactone Next is replacing the spironolactone…

Ceva Animal Health has launched Isemid (Torasemide), a once-a-day diuretic for the treatment of congestive heart failure in dogs which the company says is as effective as furosemide.

The new drug represents the fruit of 8 years of product development and…